Founded at the Abramson Cancer Center at the University of Pennsylvania

The Work of PC3I

Our initiatives are focused on clinical transformation, payment models and affordability, and incentives to change behaviors, harnessing the insights of Penn’s renowned medical researchers, data scientists, healthcare and behavioral economists, and innovators.

We employ a health equity lens across our work, examining and addressing socioeconomic, racial, and ethnic disparities and other systemic barriers to accessing high quality, patient-centered healthcare.

Health Equity
Disparities in Clinical Trial Enrollment

The Impact of Insurance Coverage on Clinical Trial Enrollment Patterns

This project will evaluate both the impact of state Medicaid mandates for coverage of routine clinical-trial related costs and the impact of the ACA’s Medicaid expansion on racial and ethnic disparities in clinical trial enrollment. This research will allow for a deeper understanding of inequities in clinical trial participation as well as the impact of state and federal policies on enrollment patterns.

patient access to clinical trials

Improving Patient Access to Cancer Clinical Trials

This study, under the Lazarex Foundation IMPACT program, looks at the effect of financial reimbursement on patient enrollment and retention, as well as ethnic/racial diversity, in clinical cancer trials at Abramson Cancer Center.

Transforming Cancer Care

Learn Moreright facing arrow